Rahmathulla Gazanfar, Barnett Gene H
Department of Neurosurgery, The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological and Taussig Cancer Institutes, Cleveland Clinic, Cleveland, Ohio, United States ; Department of Neurosurgery, Mayo Clinic, Jacksonville, Florida.
Department of Neurosurgery, The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological and Taussig Cancer Institutes, Cleveland Clinic, Cleveland, Ohio, United States.
Surg Neurol Int. 2013 Nov 20;4(Suppl 6):S411-21. doi: 10.4103/2152-7806.121612. eCollection 2013.
Craniopharyngiomas (CPs) are slow growing tumors with an incidence of between 1.2% and 4.6%, having a bimodal age distribution typically peaking in childhood and in adults between 45 and 60 years. Recurrences occur even after documented gross total resections necessitating a combination of therapeutic strategies. Obtaining a cure of this tumor in adults without producing major side effects continues to remain elusive.
We describe our results in 11 patients with CP treated in a minimally invasive fashion using a combination of techniques like burr hole aspiration, Ommaya reservoir placement, ventriculo-peritoneal (VP) shunting and focal radiation (Gamma Knife stereotactic radiosurgery/Intensity modulated radiotherapy [GKRS/IMRT]).
Visual function remained intact in all patients; endocrine status remained stable with two patients developing new postoperative diabetes insipidus. There was no periprocedural morbidity or mortality, with hospital stays for any in-patient procedure being 48 hours or less.
Minimally invasive techniques such as cyst aspiration, insertion of a catheter with Ommaya reservoir, when combined with stereotactic radiosurgery/IMRT is an effective and safe option for management and long-term control of adult CPs. We believe the Ommaya catheter by itself could act as a stent, creating a tract allowing gradual drainage of cyst fluid and stabilization without necessitating any further interventions in selected cases.
颅咽管瘤(CPs)是生长缓慢的肿瘤,发病率在1.2%至4.6%之间,具有双峰年龄分布,通常在儿童期和45至60岁的成年人中达到高峰。即使在记录为全切除术后仍会复发,因此需要综合治疗策略。在不产生重大副作用的情况下治愈成人这种肿瘤仍然难以实现。
我们描述了11例采用微创方式治疗的颅咽管瘤患者的结果,使用了诸如钻孔抽吸、置入Ommaya储液器、脑室-腹腔(VP)分流和局部放疗(伽玛刀立体定向放射外科/调强放疗[GKRS/IMRT])等技术的组合。
所有患者的视觉功能均保持完好;内分泌状态保持稳定,两名患者出现新的术后尿崩症。围手术期无发病率或死亡率,任何住院手术的住院时间均为48小时或更短。
诸如囊肿抽吸、置入带Ommaya储液器的导管等微创技术,与立体定向放射外科/IMRT联合使用时,是管理和长期控制成人颅咽管瘤的有效且安全的选择。我们认为Ommaya导管本身可作为支架,形成一条通道,使囊肿液逐渐引流并稳定,在某些情况下无需进一步干预。